Background: Epstein-Barr virus (EBV) related nasopharyngeal cancer (NPC) is endemic in Southern China and Southeast Asia. Limited studies of tumor-immune microenvironment (TIME) modulated by dual ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and ...

Background: Discordance between Epstein-Barr virus-encoded small RNA (EBER) and Epstein-Barr virus (EBV) DNA status has been observed in certain NPC patients. We aimed to elucidate the prognostic ...

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

One of the primary nasopharyngeal cancer causes is infection with the Epstein-Barr virus (EBV), which may alter the DNA of cells in the nasopharynx, leading to uncontrolled growth.

A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and facial droop on the left side. Computed tomography showed a nasopharyngeal mass. A diagnosis was made.

Oncologists play a pivotal role in diagnosing and managing nasopharyngeal cancer (NPC). Deborah Wong, MD, PhD, led a discussion on the challenges and strategies in diagnosing and treating NPC at a ...

EBV is the single most common cause of mononucleosis, often referred to as "mono". The virus can, albeit rarely, lead to serious conditions such as nasopharyngeal cancers and some types of lymphoma.

Positive opinion for TEVIMBRA in combination with chemotherapy as a first-line treatment of nasopharyngeal cancer (NPC) based on results of RATIONALE-309 study demonstrating statistically ...